Residual neuromuscular blockade / recurarisation
Incomplete reversal · Perioperative & Anaesthesia
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Persistent or recurring neuromuscular weakness after anaesthesia from incompletely reversed non-depolarising block (TOF ratio <0.9), risking airway obstruction, hypoventilation and aspiration in recovery. Recurarisation describes return of block after apparent reversal.
Red flags
- Upper airway obstruction or tracheal tug in recovery
- Hypoventilation with rising CO2 and falling SpO2
- Inability to sustain head lift or maintain airway
- Weakness recurring after apparent reversal (recurarisation)
- Aspiration or regurgitation during weakness
- Agitation/distress from paralysis with inadequate ventilation
Assessment
Differential diagnosis
- Inadequate dose/timing of reversal relative to depth of block
- Neostigmine ceiling effect given at deep block (reappearance of block)
- Renal/hepatic impairment prolonging relaxant or reversal clearance
- Potentiating factors (hypothermia, acidosis, hypokalaemia, hypermagnesaemia, aminoglycosides)
- Neuromuscular disease (myasthenia gravis, Eaton-Lambert)
- Sugammadex re-dosing errors or displacement by other drugs
Investigations
- Quantitative train-of-four monitoring (aim TOF ratio >0.9)
- Clinical tests: sustained 5-second head lift, hand grip, tongue protrusion, adequate tidal volume
- ABG if hypoventilating (rising CO2)
- Electrolytes, magnesium, renal function, temperature
- Review relaxant and reversal doses and timing
Management
- Suspect residual block in any post-extubation weakness, jerky breathing, tracheal tug or desaturation
- Support the airway, give oxygen and assist ventilation as needed
- Confirm with quantitative TOF monitoring rather than clinical signs alone
- If rocuronium/vecuronium block, give sugammadex at the appropriate dose for depth
- If other relaxants and shallow block with intact TOF response, give neostigmine with an antimuscarinic
- Correct potentiating factors: warm the patient, correct acidosis, electrolytes
- Keep the patient sitting up and monitored until full recovery confirmed
- Avoid sedatives/opioids that worsen hypoventilation until recovered
- Re-intubate if airway/ventilation inadequate
- Document and investigate predisposing causes
Drugs & doses
Sugammadex 2 mg/kg IV (TOF reappearing), 4 mg/kg IV (deep block, 1-2 post-tetanic counts), 16 mg/kg for immediate reversal
Neostigmine 0.04-0.05 mg/kg IV (max ~5 mg) with glycopyrrolate 10-15 microgram/kg or atropine
Avoid neostigmine at very deep block (can worsen/prolong)
Calcium or correction of hypermagnesaemia if contributory
Oxygen and airway support as needed
Disposition
Keep in a monitored recovery area until quantitative reversal is confirmed; patients with recurrent weakness, high CO2 or aspiration need critical care and consultant review.
Complications & pitfalls
- Hypoxaemia and hypercapnia
- Aspiration pneumonitis
- Airway obstruction/arrest
- Awareness if sedation lifts before paralysis
- Postoperative respiratory failure/reintubation
Exam pearls
- Clinical signs are unreliable; only quantitative TOF ratio >0.9 confirms adequate reversal
- Neostigmine has a ceiling and can paradoxically worsen very deep block; sugammadex is depth-appropriate for aminosteroid relaxants
- Hypothermia, acidosis and hypomagnesaemia all prolong block
- Giving sugammadex too early relative to re-anaesthesia, or a second aminosteroid soon after, risks errors
- Sit the patient up and keep monitoring; recurarisation can appear in recovery
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.